• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Down 2%; GE Aerospace Earnings Top Views

    7/23/24 12:03:18 PM ET
    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADIL alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday.

    The Dow traded up 0.09% to 40,452.70 while the NASDAQ rose 0.62% to 18,119.84. The S&P 500 also rose, gaining, 0.32% to 5,582.32.

    Check This Out: How To Earn $500 A Month From Alphabet Stock Ahead Of Q2 Earnings Report

    Leading and Lagging Sectors

    Consumer discretionary shares jumped by 1% on Tuesday.

    In trading on Tuesday, energy shares fell by 1.4%.

    Top Headline

    GE Aerospace (NYSE:GE) reported better-than-expected second-quarter earnings and raised its FY24 outlook.

    GE Aerospace reported second-quarter 2024 adjusted revenue growth of 4% year-over-year to $8.22 billion, missing the consensus of $8.462 billion. Adjusted EPS was $1.20 (+61% YoY), beating the consensus of 99 cents.

    Equities Trading UP
                           

    • Azitra, Inc. (NYSE:AZTR) shares shot up 455% to $9.00 after the company announced that the U.S. Patent and Trademark Office granted it U.S. Patent No. 12,036,248 for the treatment of atopic dermatitis.
    • Shares of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) got a boost, surging 62% to $1.7150 after the company announced it advanced into the second cohort and commenced dosing for the Pharmacokinetics Study of AD04 for alcohol use disorder.
    • Frequency Electronics, Inc. (NASDAQ:FEIM) shares were also up, gaining 30% to $13.15 following fourth-quarter earnings. Also, the company declared a $1.00 special cash dividend.

    Equities Trading DOWN

    • Jaguar Health, Inc. (NASDAQ:JAGX) shares dropped 64% to $1.5387 after the company announced its phase 3 OnTarget trial results for Crofelemer did not meet its primary endpoint.
    • Shares of TransCode Therapeutics, Inc. (NASDAQ:RNAZ) were down 62% to $0.2997 after the company priced $3 million public offering of 10 million common shares at $0.30 per share.
    • Cellectar Biosciences, Inc. (NASDAQ:CLRB) was down, falling 24% to $2.2850. The company announced results from its CLOVER WaM pivotal study evaluating iopofosine I 131.

    Also Check This Out: Wall Street’s Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks With Over 3% Dividend Yields

    Commodities

    In commodity news, oil traded down 2% to $76.86 while gold traded up 0.4% at $2,405.00.

    Silver traded down 0.5% to $29.19 on Tuesday, while copper fell 0.9% to $4.16.

    Euro zone

    European shares were mixed today. The eurozone's STOXX 600 climbed 0.07%, Germany's DAX gained 0.68% and France's CAC 40 fell 0.33%. Spain's IBEX 35 Index rose 0.57%, while London's FTSE 100 fell 0.43%.

    Asia Pacific Markets

    Asian markets closed lower on Tuesday, with Japan's Nikkei 225 falling 0.01%, Hong Kong's Hang Seng Index falling 0.94%, China's Shanghai Composite Index declining 1.65% and India's S&P BSE Sensex declining 0.09%.

    The annual inflation rate in Hong Kong rose to 1.5% in June from 1.2% in the prior month. The People’s Bank of China slashed one-year loan prime rate by 10bps to 3.35%.

    Economics

    The composite manufacturing index in the US Fifth District fell to -17 in July compared to a reading of -10 in June.

    Existing home sales declined by 5.4% from the prior month to an annualized rate of 3.89 million units for June.

    Now Read This:

    • This Coinbase Global Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $AZTR
    $CLRB
    $FEIM

    CompanyDatePrice TargetRatingAnalyst
    GE Aerospace
    $GE
    12/12/2025$386.00Buy
    Citigroup
    GE Aerospace
    $GE
    12/4/2025$350.00Positive
    Susquehanna
    GE Aerospace
    $GE
    11/18/2025Underperform
    BNP Paribas Exane
    Frequency Electronics Inc.
    $FEIM
    9/18/2025$43.00Buy
    Craig Hallum
    GE Aerospace
    $GE
    5/19/2025Buy → Neutral
    Northcoast
    GE Aerospace
    $GE
    4/9/2025$205.00Neutral → Buy
    Northcoast
    GE Aerospace
    $GE
    2/18/2025$250.00Buy
    Redburn Atlantic
    GE Aerospace
    $GE
    1/7/2025Neutral
    Northcoast
    More analyst ratings

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Caruso James V bought $49,900 worth of shares (10,000 units at $4.99), increasing direct ownership by 611% to 11,638 units (SEC Form 4)

    4 - Cellectar Biosciences, Inc. (0001279704) (Issuer)

    7/3/25 8:02:08 AM ET
    $CLRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operating Officer Longcor Jarrod bought $49,900 worth of shares (10,000 units at $4.99), increasing direct ownership by 361% to 12,768 units (SEC Form 4)

    4 - Cellectar Biosciences, Inc. (0001279704) (Issuer)

    7/3/25 8:01:18 AM ET
    $CLRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Kolean Chad J bought $24,950 worth of shares (5,000 units at $4.99), increasing direct ownership by 353% to 6,418 units (SEC Form 4)

    4 - Cellectar Biosciences, Inc. (0001279704) (Issuer)

    7/3/25 8:00:13 AM ET
    $CLRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

    BRANFORD, Conn., Feb. 6, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced its Special Meeting scheduled for and convened on February 6, 2026, (the "Special Meeting") has been adjourned until March 6, 2026, at 11:00 a.m. Eastern Time (the "Reconvened Special Meeting") for the purpose of soliciting additional votes with respect to the proposals outlined below and described in the Company's definitive proxy statement for the Special Meeting filed with the U.S. Securities and Exchange Commission (the "SEC") on January 2, 2026 (the "Special Meeting Proxy Statement") becau

    2/6/26 4:15:00 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GE Aerospace Board of Directors Authorizes Quarterly Dividend

    CINCINNATI, Feb. 6, 2026 /PRNewswire/ -- The Board of Directors of GE Aerospace (NYSE:GE) today declared a $0.47 per share dividend on the outstanding common stock of the Company. The dividend is payable April 27, 2026, to shareholders of record at the close of business on March 9, 2026. The ex-dividend date is March 9, 2026. About GE Aerospace GE Aerospace (NYSE:GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 50,000 commercial and 30,000 military aircraft engines. With a global team of approximately 57,000 employees b

    2/6/26 1:34:00 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138

    BOSTON, Feb. 5, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ:RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, in collaboration with Quantum Leap Healthcare Collaborative (Quantum Leap), today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational New Drug (IND) application amendment for a planned Phase 2a clinical trial with TransCode's lead therapeutic candidate, TTX-MC138. The study will be conducted by Quantum Leap within their PRE-I-SPY program, a leading platform for innovative oncology clinical trials, and represents the program's first exp

    2/5/26 8:04:00 AM ET
    $RNAZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    SEC Filings

    View All

    SEC Form DEFA14A filed by Azitra Inc

    DEFA14A - Azitra, Inc. (0001701478) (Filer)

    2/6/26 4:17:06 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Azitra, Inc. (0001701478) (Filer)

    2/6/26 4:15:22 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 13F-HR filed by GE Aerospace

    13F-HR - GENERAL ELECTRIC CO (0000040545) (Filer)

    2/5/26 10:32:31 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Senior Vice President Procacci Riccardo sold $248,088 worth of shares (800 units at $310.11), decreasing direct ownership by 5% to 15,939 units (SEC Form 4)

    4 - GENERAL ELECTRIC CO (0000040545) (Issuer)

    2/4/26 4:16:56 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Senior Vice President Gowder Amy L sold $1,222,920 worth of shares (4,000 units at $305.73), decreasing direct ownership by 19% to 16,535 units (SEC Form 4)

    4 - GENERAL ELECTRIC CO (0000040545) (Issuer)

    2/3/26 4:52:39 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Senior Vice President Stokes Russell exercised 30,363 shares at a strike of $148.80 and sold $9,305,490 worth of shares (30,363 units at $306.47) (SEC Form 4)

    4 - GENERAL ELECTRIC CO (0000040545) (Issuer)

    2/3/26 4:50:35 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on GE Aerospace with a new price target

    Citigroup initiated coverage of GE Aerospace with a rating of Buy and set a new price target of $386.00

    12/12/25 8:50:39 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Susquehanna initiated coverage on GE Aerospace with a new price target

    Susquehanna initiated coverage of GE Aerospace with a rating of Positive and set a new price target of $350.00

    12/4/25 8:43:31 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    BNP Paribas Exane initiated coverage on GE Aerospace

    BNP Paribas Exane initiated coverage of GE Aerospace with a rating of Underperform

    11/18/25 9:38:27 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cellectar Biosciences Inc.

    SC 13G/A - Cellectar Biosciences, Inc. (0001279704) (Subject)

    11/14/24 4:47:59 PM ET
    $CLRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adial Pharmaceuticals Inc

    SC 13G/A - ADIAL PHARMACEUTICALS, INC. (0001513525) (Subject)

    11/14/24 3:44:01 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cellectar Biosciences Inc.

    SC 13G/A - Cellectar Biosciences, Inc. (0001279704) (Subject)

    11/14/24 1:26:20 PM ET
    $CLRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Leadership Updates

    Live Leadership Updates

    View All

    TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors

    BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, announced the appointment of Jack E. Stover to its Board of Directors. Mr, Stover will join the Audit and the Nominating Committees as Dr. Magda Marquet steps down from the Audit Committee.  Mr. Stover brings more than three decades of executive leadership experience across public and private life sciences companies, spanning drug development, diagnostics, specialty pharmaceuticals, and capital formation.

    12/22/25 8:01:00 AM ET
    $RNAZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer

    Accomplished drug development leader to advance TransCode's mission of defeating cancer through RNA innovation and translational excellence BOSTON, Nov. 17, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ:RNAZ), an immuno-oncology and targeted cancer therapy company with a focus on treating advanced malignancy, announced today the appointment of Dr. Michel Janicot, Ph.D., as consultant Senior Development Officer. Dr. Janicot brings more than 35 years of experience in pharmaceutical research, preclinical, and early clinical drug development across oncology and other therapeutic areas. He will serve initially on a part-time basis. 

    11/17/25 8:01:00 AM ET
    $RNAZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GE AEROSPACE AND BETA TECHNOLOGIES PARTNER TO ADVANCE HYBRID ELECTRIC FLIGHT

    Companies to co-develop hybrid electric turbogenerator for defense and civil applications, enabling U.S. Advanced Air MobilityHybrid electric capabilities enable longer range, higher speed, lower operating cost and higher payload compared to other aircraft in the same segmentGE Aerospace to make an equity investment of $300 million in BETA Technologies, Inc.CINCINNATI, Sept. 4, 2025 /PRNewswire/ -- GE Aerospace (NYSE:GE) and BETA Technologies Inc. ("BETA") announced today a new strategic partnership and equity investment agreement, subject to regulatory approval, to accelerate the development of hybrid electric aviation by combining BETA's rapid innovation approach with GE Aerospace's global

    9/4/25 6:20:00 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $ADIL
    $AZTR
    $CLRB
    $FEIM
    Financials

    Live finance-specific insights

    View All

    GE Aerospace Board of Directors Authorizes Quarterly Dividend

    CINCINNATI, Feb. 6, 2026 /PRNewswire/ -- The Board of Directors of GE Aerospace (NYSE:GE) today declared a $0.47 per share dividend on the outstanding common stock of the Company. The dividend is payable April 27, 2026, to shareholders of record at the close of business on March 9, 2026. The ex-dividend date is March 9, 2026. About GE Aerospace GE Aerospace (NYSE:GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 50,000 commercial and 30,000 military aircraft engines. With a global team of approximately 57,000 employees b

    2/6/26 1:34:00 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Frequency Electronics, Inc. Announces Second Quarter and Fiscal Year 2026 Financial Results

    MITCHEL FIELD, N.Y., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. ("FEI" or the "Company") (NASDAQ-FEIM) is pleased to announce its financial results for the second quarter and fiscal year 2026. Revenue for the three and six months ended October 31, 2025, was approximately $17.1 million and $30.9 million, respectively, compared to $15.8 million and $30.9 million, respectively, reported for the same period of fiscal year 2025. Operating income for the three and six months ended October 31, 2025 was $1.7 million and $2.1 million, respectively, compared to $2.6 million and $5.0 million, respectively, reported for the same period of the previous fiscal year. Net Income from o

    12/11/25 4:03:00 PM ET
    $FEIM
    Electrical Products
    Industrials

    Frequency Electronics Announces Second Quarter Fiscal 2026 Financial Results Conference Call: Thursday, December 11, 2025, at 4:30 PM ET

    MITCHEL FIELD, N.Y., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (NASDAQ:FEIM), will hold a conference call to discuss results for the second quarter of its fiscal year 2026, ended October 31, 2025, on Thursday, December 11, 2025, at 4:30 PM Eastern Time. This call is being webcast by Issuer Direct Corporation and can be accessed in the Investor Relations section of Frequency's web site at www.freqelec.com. Investors and analysts may also access the call by dialing 888-506-0062. International callers may dial 973-528-0011. Callers should provide participant access code: 533796 or ask for the Frequency Electronics conference call. A telephone replay of the archived call

    12/9/25 4:01:00 PM ET
    $FEIM
    Electrical Products
    Industrials